Frontiers in physiology · 2025
The impact of blood flow restriction combined with variable resistance training at different loads on lower limb strength and explosiveness in collegiate basketball players.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Peng Wuwen, Zhang Zhanming, Lu Di, Li Zhentao, Li Guoxing, Sun Jian, Li Duanying
Аннотация
UNLABELLED: This study compared the effects of an 8-week program of low-load blood flow restriction training combined with chain-based variable resistance training (BFR-VRT) and high-load chain-based variable resistance training (VRT) on lower-limb performance in male college basketball players. A total of 27 players were randomly assigned to the BFR-VRT group (n = 9), the variable resistance training group (n = 9), or a control group (n = 9). The BFR-VRT protocol used pneumatic cuffs applied to the proximal thighs, with training pressure set at 180 mmHg, and combined a 10% 1RM barbell load with 10%-30% 1RM from chains, whereas the VRT protocol consisted of a 55% 1RM barbell load plus 10%-30% 1RM from chains. The control group did not receive any resistance training. Repeated-measures Repeated-measures ANOVA showed significant within-group improvements in SQ-1RM, LTC, RTC, countermovement jump, squat jump, DJ-RSI, standing long jump, and 30-m in both the BFR-VRT and VRT groups (all p < 0.05), whereas the CON group showed no significant change (p > 0.05). Between-group comparisons indicated no significant differences among the three groups on these outcomes (all p > 0.05). In conclusion, both BFR-VRT and VRT improved lower-limb performance; under a lower external load, BFR-VRT showed effects comparable to, or trending greater than, VRT on certain performance measures.
CLINICAL TRIAL REGISTRATION: https://www.chictr.org.cn/showprojEN.html?proj=201896, identifier ChiCTR2400086132.
CLINICAL TRIAL REGISTRATION: https://www.chictr.org.cn/showprojEN.html?proj=201896, identifier ChiCTR2400086132.